Three years kashtanka mobi sitemap76 xml "There is going to be new information generated there thatyou would never get unless you followed patients through firstrelapse and second relapse and beyond," said George Mulligan,director of translational medicine for MillenniumPharmaceuticals, Takeda's oncology unit.